ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
- PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Estradiol Gel, 0.06%. ANI's Estradiol Gel, 0.06% is the generic version of the reference listed drug (RLD) EstroGel® Gel, 0.06%.
- 10/25/2024
|
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
- Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care
- 10/24/2024
|
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/21/2024
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- 10/17/2024
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 10/16/2024
|
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?
- ANI (ANIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/15/2024
|
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
- Piper Sandler has initiated coverage on ANI Pharmaceuticals ANIP, an integrated specialty pharmaceutical firm that develops and markets branded and generic medicines.
- 10/11/2024
|
ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market
- Today, we revisit small biopharma ANI Pharmaceuticals, as it is a GARP stock trading near technical support, with solid growth prospects. The company recently acquired Alimera Sciences for $380 million, boosting its rare disease segment with a couple of durable ophthalmology products. Analyst firms are generally bullish on the company's prospects and the stock trades at 12 times trailing earnings, despite revenue growth in the high teens.
- 10/11/2024
|
Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know
- The consensus price target hints at a 43% upside potential for ANI (ANIP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 10/09/2024
|
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/27/2024
|
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
- PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Ketoconazole Shampoo, 2%. ANI's Ketoconazole Shampoo, 2% is the generic version of the reference listed drug (RLD) Nizoral®.
- 09/26/2024
|
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
- PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”).
- 09/16/2024
|
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
- PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc. (Nasdaq: ALIM).
- 09/16/2024
|
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
- PRINCETON, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution, 6.25 mg/15 mg per 5 mL.
- 09/13/2024
|
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
- PRINCETON, N.J. and ATLANTA, Sept.
- 09/11/2024
|
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
- PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. (“Alimera”) (Nasdaq: ALIM).
- 09/10/2024
|
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/15/2024
|
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes
- PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In response to investor demand, ANI upsized the initial offering of $250,000,000 aggregate principal amount of notes to $275,000,000 and the initial purchasers fully exercised their option to purchase an additional $41,250,000 aggregate principal amount of the notes. The notes were issued pursuant to, and are governed by, an indenture, dated as of August 13, 2024, between the Company and U.S. Bank Trust Company, National Association, as trustee.
- 08/13/2024
|
ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Lisa Wilson - IR Nikhil Lalwani - President, CEO & Director Christopher Mutz - SVP, Head, Rare Diseases Stephen Carey - CFO & SVP Conference Call Participants Les Sulewski - Truist Securities Gary Nachman - Raymond James & Associates Vamil Divan - Guggenheim Securities Oren Livnat - H.C. Wainwright & Co. Tim Chiang - Capital One Operator Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter 2024 Earnings Results Call.
- 08/09/2024
|
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
- PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the pricing of its offering of $275,000,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $250,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on August 13, 2024, subject to customary closing conditions. ANI also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $41,250,000 principal amount of notes.
- 08/07/2024
|
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
- PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). ANI also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $37,500,000 principal amount of notes.
- 08/07/2024
|
Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics
- The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/06/2024
|
ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates
- ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $1.28 per share a year ago.
- 08/06/2024
|
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
- BAUDETTE, Minn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the three months ended June 30, 2024.
- 08/06/2024
|
Seeking Clues to ANI (ANIP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for ANI (ANIP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
- 08/05/2024
|
ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028
- ANIP has three 505(b)(2) NDA submissions under FDA review, including oral liquid terazosin, female testosterone drug, and oral liquid hydrochlorothiazide. Potential peak sales for Tezruly and hydrochlorothiazide in the US could exceed $500 million, while the female testosterone drug could generate $290 million in royalties. ANIP's revenue could reach $1.41 billion in sales and $290 million in royalties by 2028, with significant growth potential.
- 08/02/2024
|
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
- PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Powder. ANI's L-Glutamine Oral Powder is the generic version of the reference listed drug (RLD) Endari®.
- 07/15/2024
|
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
- PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP. ANI's Naproxen Delayed-Release Tablets is the generic version of the reference listed drug (RLD) EC-Naprosyn®.
- 07/02/2024
|
SHAREHOLDER ALERT: Weiss Law Investigates Alimera Sciences, Inc.
- NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alimera Sciences, Inc. ("Alimera" or the "Company") (NASDAQ:ALIM), in connection with its acquisition by ANI Pharmaceuticals, Inc. (NASDAQ: ANIP). Under the merger agreement, the Company's shareholders will receive $5.50per share in cash at closing and one non-tradable contingent value right ("CVR") to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.
- 06/26/2024
|
ANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
- Recognized for outstanding entrepreneurial leadership, driving impressive growth, and patient impact Recognized for outstanding entrepreneurial leadership, driving impressive growth, and patient impact
- 06/25/2024
|
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
- Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approximately $105 million in highly durable branded revenue Adds two commercial assets ILUVIEN ® and YUTIQ ® with significant growth potential, expanding ANI's foothold in key strategic therapeutic area of ophthalmology Anticipated to drive high single digit to low double digit accretion in adjusted non-GAAP EPS in 2025 and to be substantially accretive thereafter Expected to generate additional $35 - $38 million in 2025 adjusted non-GAAP EBITDA inclusive of approximately $10 million in identified cost synergies; additional EBITDA contribution expected from accelerated growth of Purified Cortrophin ® Gel in ophthalmology Increased geographic diversification with Alimera's established ex-US footprint, including direct operations in Europe PRINCETON, N.J.
- 06/24/2024
|
ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked
- ANIP's potential royalty revenue from two upcoming drug applications could generate $415 million annually, not reflected in the current share price. ANI Pharmaceuticals' legal action against CG Oncology could result in royalties for Cretostimogene, potentially adding $125 million per year. The Company's female testosterone drug could generate royalties of $290 million per year, with potential for additional indications and international sales.
- 06/10/2024
|
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
- BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows:
- 05/29/2024
|
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
- NEW YORK , May 20, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) on behalf of the company's shareholders. The investigation seeks to determine whether ANI Pharmaceuticals's directors breached their fiduciary duties in connection with recent corporate actions.
- 05/20/2024
|
Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround
- ANI (ANIP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 05/20/2024
|
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
- BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex® Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS® Suspension for Oral or Rectal use.
- 05/20/2024
|
Gilead (GILD) Announces Positive Interim Results on PBC Drug
- Gilead Sciences, Inc. (GILD Quick QuoteGILD - Free Report) announced positive interim results from the ongoing ASSURE study on pipeline candidate seladelpar.ASSURE is an open-label study evaluating the long-term safety and efficacy of seladelpar, a once-daily potent and selective peroxisome proliferator-activated receptor (PPAR) delta agonist or delpar.Seladelpar is a first-in-class oral, selective PPAR-delta agonist or delpar is being evaluated for treating primary biliary cholangitis (PBC).The study enrolled adult patients with PBC who previously participated in a study of seladelpar where a key eligibility criterion included an inadequate response or intolerance to ursodeoxycholic acid (UDCA). Most patients enrolled in ASSURE were female (94%), with a mean age of 59 years.PBC is a rare, chronic, cholestatic liver disease mainly affecting women.We remind investors that the candidate was added to Gilead’s pipeline following the recent acquisition of CymaBay Therapeutics, Inc. The interim results showed that treatment with seladelpar led to improvements in markers of cholestasis and reduced inflammation. Additional findings demonstrate that seladelpar can help reduce pruritus (itch) in people living with PBC.This analysis did not include patients from the late-stage RESPONSE study, which will be reported separately.The study also evaluated several prespecified biochemical endpoints, including the composite response of alkaline phosphatase (ALP) below 1.67 x upper limit of normal (ULN), a decline in ALP of at least 15% and total bilirubin (TB) below the ULN.70% of patients receiving seladelpar 10mg achieved the clinically meaningful composite endpoint and 37% achieved ALP normalization at 12 months.The reduction in patient-reported pruritus was rapid and durable in patients with moderate to severe symptoms.Please note that a new drug application (NDA) for seladelpar for the treatment of PBC, including pruritus, in adults without cirrhosis or with compensated cirrhosis (Child Pugh A) who are inadequate responders or intolerant to UDCA is under review in the United States.The FDA granted priority review to the NDA and set a target action date of Aug 14, 2024. The candidate is also under review in Europe.Seladelpar received FDA Breakthrough Therapy Designation for the treatment of PBC, including pruritus in patients without cirrhosis or with compensated cirrhosis and PRIME status (EMA) and Orphan Drug Designation in the United States and Europe for treating patients with PBC.Gilead’s shares have lost 16.4% year to date compared with the industry's decline of 5%. Image Source: Zacks Investment ResearchLast month, GILD reported better-than-expected results for the first quarter of 2024 as its loss was narrower than expected and sales beat estimates.Gilead Sciences, Inc. Price, Consensus and EPS Surprise Gilead Sciences, Inc. price-consensus-eps-surprise-chart | Gilead Sciences, Inc. Quote The company intends to expand its portfolio beyond the HIV franchise. The acquisition of CymaBay complements Gilead’s existing liver portfolio and a potential approval of seladelpar for PBC will strengthen this franchise.Intercept Pharmaceuticals’ Ocaliva (obeticholic acid) received accelerated approval from the FDA in 2016 for the treatment of adult patients living with PBC without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension, either in combination with UDCA with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA.Zacks Rank & Stocks to ConsiderGilead currently carries a Zacks Rank #5 (Strong Sell).A couple of better-ranked stocks from the healthcare industry are Ligand Pharmaceuticals (LGND Quick QuoteLGND - Free Report) and ANI Pharmaceuticals (ANIP Quick QuoteANIP - Free Report) . Both stocks carry a Zacks Rank #2 (Buy). In the past 30 days, the Zacks Consensus Estimate for Ligand’s 2024 and 2025 earnings per share (EPS) has remained constant at $4.56 and $5.27, respectively. Shares of LGND are up 20.5% year to date.In the past 60 days, estimates for ANI Pharmaceuticals’ 2024 EPS have improved from $4.43 to $4.44. Shares of ANIP have jumped 11.4% year to date. ANIP’s earnings beat estimates in each of the trailing four quarters, delivering an earnings surprise of 53.90%, on average. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
- 05/20/2024
|
ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President and Chief Executive Officer Stephen Carey - Senior Vice President, Finance and Chief Financial Officer Conference Call Participants Gary Nachman - Raymond James Leszek Sulewski - Truist Securities Vamil Divan - Guggenheim Securities Oren Livnat - H.C. Wainwright Timothy Chiang - Capital One Operator Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2024 Earnings Results Call.
- 05/10/2024
|
ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for ANI (ANIP) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 05/10/2024
|
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
- BAUDETTE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the three months ended March 31, 2024.
- 05/10/2024
|
Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)
- ANI Pharmaceuticals (ANIP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 05/09/2024
|
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
- ANI Pharmaceuticals' (ANIP) revenues in the first quarter of 2024 are likely to have been driven by increased sales of its lead product, Cortrophin Gel, as well as growth in its generics business.
- 05/06/2024
|
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/03/2024
|
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
- BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences in New York City as follows:
- 05/01/2024
|
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
- BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2024 financial results on Friday, May 10, 2024, prior to the market open.
- 04/18/2024
|
Why ANI (ANIP) is Poised to Beat Earnings Estimates Again
- ANI (ANIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/15/2024
|
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
- BAUDETTE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the reference listed drug (RLD) Fleqsuvy®.
- 04/09/2024
|
Wall Street Analysts Think ANI (ANIP) Is a Good Investment: Is It?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 04/05/2024
|
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
- --ANI Pharmaceuticals is proud to support Sarcoidosis disease awareness-- --ANI Pharmaceuticals is proud to support Sarcoidosis disease awareness--
- 04/04/2024
|
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
- BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 17, 2024, at the Encore Boston Harbor.
- 04/03/2024
|
ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- ANI Pharmaceuticals (ANIP) concluded the recent trading session at $69.69, signifying a +0.2% move from its prior day's close.
- 03/27/2024
|
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
- BAUDETTE, Minn., March 27, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Levofloxacin Oral Solution, a generic version of the Reference Listed Drug (RLD) Levaquin®. The current annual U.S. market for Levofloxacin Oral Solution is approximately $7.1 million, according to latest estimates from IQVIA/IMS Health, a leading healthcare data and analytics provider.
- 03/27/2024
|
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/26/2024
|
ANI (ANIP) Is Considered a Good Investment by Brokers: Is That True?
- The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
- 03/20/2024
|
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
- Here is how ANI Pharmaceuticals (ANIP) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.
- 03/14/2024
|
Top 10 Small-Cap Stocks (SA Quant)
- The prevailing market sentiment is currently fueled by the allure of "The Magnificent 7" and stocks with high upside potential. Over the last 52 weeks, the S&P 500 is up ~28% compared to the S&P Small-Cap index (~+15%). Small-cap stocks present enticing prospects for growth and value for investors willing to capitalize on calculated risks. The S&P 500 P/E is 25x vs. the S&P Small-Cap at 14.8x.
- 03/12/2024
|
What Makes ANI Pharmaceuticals (ANIP) a Strong Momentum Stock: Buy Now?
- Does ANI Pharmaceuticals (ANIP) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 03/06/2024
|
Wall Street Analysts See ANI (ANIP) as a Buy: Should You Invest?
- When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
- 03/01/2024
|
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?
- ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/01/2024
|
Compared to Estimates, ANI (ANIP) Q4 Earnings: A Look at Key Metrics
- The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/29/2024
|
Unveiling ANI (ANIP) Q4 Outlook: Wall Street Estimates for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for ANI (ANIP), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
- 02/26/2024
|
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/22/2024
|
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
- BAUDETTE, Minn., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Leerink Partners Global Biopharma Conference in Miami Beach as follows:
- 02/20/2024
|
ANI Pharmaceuticals (ANIP) Advances While Market Declines: Some Information for Investors
- The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $57.03, representing a +0.92% change from its previous close.
- 02/12/2024
|
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET
- BAUDETTE, Minn., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, prior to the market open.
- 02/07/2024
|
ANI Pharmaceuticals (ANIP) Ascends While Market Falls: Some Facts to Note
- The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $56.04, representing a +1.12% change from its previous close.
- 02/05/2024
|
ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- ANI Pharmaceuticals (ANIP) reachead $55.02 at the closing of the latest trading day, reflecting a +0.7% change compared to its last close.
- 01/29/2024
|
ANI Pharmaceuticals (ANIP) Beats Stock Market Upswing: What Investors Need to Know
- In the most recent trading session, ANI Pharmaceuticals (ANIP) closed at $56.17, indicating a +1.37% shift from the previous trading day.
- 01/22/2024
|
ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note
- ANI Pharmaceuticals (ANIP) closed at $55.41 in the latest trading session, marking a -0.32% move from the prior day.
- 01/19/2024
|
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
- BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows:
- 11/22/2023
|
ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Judy DiClemente - Insight Communications IR Nikhil Lalwani - President and CEO Stephen Carey - CFO Conference Call Participants Les Sulewski - Truist Securities Vamil Divan - Guggenheim Securities Oren Livnat - H.C. Wainwright Operator Good day, everyone, and welcome to the ANI Pharmaceuticals, Inc. Third Quarter 2023 Earnings Results Call.
- 11/08/2023
|
ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note
- ANI Pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from the prior day.
- 11/01/2023
|
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET
- BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial results on Wednesday, November 8, 2023, prior to the market open.
- 10/25/2023
|
ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know
- ANI Pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from the prior day.
- 10/20/2023
|
ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why
- The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $58.39, representing a -0.41% change from its previous close.
- 10/06/2023
|
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
- BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City as follows:
- 09/18/2023
|
Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio
- ANI Pharmaceuticals (ANIP), a top-ranked stock, has a diverse portfolio of rare disease and generic medicines. Its Purified Cortrophin Gel is witnessing incremental sales in recent quarters.
- 09/11/2023
|
ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why
- If you are looking for stocks that are well positioned to maintain their recent uptrend, ANI (ANIP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- 09/08/2023
|
What Makes ANI (ANIP) a New Strong Buy Stock
- ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 08/25/2023
|
New Strong Buy Stocks for August 25th
- ANIP, NVMI, AZPN, GRNT and CVLG have been added to the Zacks Rank #1 (Strong Buy) List on August 25, 2023.
- 08/25/2023
|
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference in New York City as follows:
- 08/24/2023
|
Here's Why Momentum in ANI (ANIP) Should Keep going
- If you are looking for stocks that are well positioned to maintain their recent uptrend, ANI (ANIP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- 08/23/2023
|
ANI (ANIP) Reports Q2 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for ANI (ANIP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 08/09/2023
|
ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue Estimates
- ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.13 per share a year ago.
- 08/09/2023
|
ANI Pharmaceuticals (ANIP) to Post Q2 Earnings: What's in Store?
- ANI Pharmaceuticals' (ANIP) second-quarter 2023 performance is likely to have been driven by rising generic and rare disease product revenues.
- 07/31/2023
|
ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
- BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2023 financial results on Wednesday, August 9, 2023, prior to the market open.
- 07/31/2023
|
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
- Here is how ANI Pharmaceuticals (ANIP) and ImmunoGen (IMGN) have performed compared to their sector so far this year.
- 07/18/2023
|
ANI Pharmaceuticals Is Undervalued When Considering Their Unadvertised Pipeline
- ANIP Pharmaceuticals has not yet published a pipeline of products under development or out-licensed, leaving investors in the dark about future revenue opportunities. The company has a range of drugs in various stages of development, including treatments for rheumatic disorders, nervous system conditions, respiratory diseases, and metabolic disorders. Key drugs in phase 3 trials include a treatment for hypoactive sexual desire disorder and several cardiovascular treatments, with significant clinical trial results expected by October 2023.
- 07/05/2023
|
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
- Here is how ANI Pharmaceuticals (ANIP) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.
- 06/22/2023
|
ANI Pharmaceuticals: Strong Revenue Growth And ANDA Approvals
- ANI Pharmaceuticals exceeded Q1 Non-GAAP earnings expectations and raised its guidance to $385-$410 million. The company has a diverse product portfolio and strong relationships in the generic drug market. Despite high debt levels, ANI Pharmaceuticals is a strong buy due to its revenue growth and potential to increase profitability.
- 05/30/2023
|
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Healthcare Conference in New York City as follows: Date: Friday, June 9, 2023 Time: 8:30 a.m. ET Webcast: Click here The live and archived webcast of the presentation will be accessible from the Company's website at www.
- 05/22/2023
|
ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates
- ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to loss of $0.12 per share a year ago.
- 05/08/2023
|
New Strong Sell Stocks for March 13th
- ANIP, ARCB and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on March 13, 2023.
- 03/13/2023
|
ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Top Estimates
- ANI (ANIP) delivered earnings and revenue surprises of 11.76% and 8.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 03/09/2023
|
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, prior to market open. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Thursday, March 9, 2023 Time 8:30 a.m.
- 02/22/2023
|
2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit
- Results from three major testosterone trials expected in 2023, including the largest testosterone cardiovascular safety/efficacy trials for men and women. AbbVie led Androgel 1.62% 5,246-participant cardiovascular safety trial is also measuring efficacy for dysthymia, clinical fractures, anemia, and progression from pre-diabetes to diabetes, results could lead to sNDA submissions.
- 01/01/2023
|
ANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q3 2022 Earnings Conference Call November 9, 2022 8:00 AM ET Company Participants Judy DiClemente - IR Nikhil Lalwani - President and CEO Steve Carey - CFO Christopher Mutz - Head, Rare Disease Conference Call Participants Elliot Wilbur - Raymond James Brandon Folkes - Cantor Fitzgerald Greg Fraser - Truist Securities Operator Good morning, everyone. My name is Todd, and I'll be your conference operator.
- 11/09/2022
|
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
- ANI (ANIP) delivered earnings and revenue surprises of 10.34% and 6.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/09/2022
|
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
- BAUDETTE, Minn.
- 10/24/2022
|
ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference as follows: Date: Monday, September 12, 2022 Time: 12:30PM ET Webcast: Click Here The webcast will be accessible via the Company's website at www.anipharmaceuticals.com, in the Investors section under Events an
- 08/30/2022
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2022 Earnings Conference Call August 8, 2022 8:00 AM ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President & Chief Executive Officer Steve Carey - Chief Financial Officer, Senior Vice President of Finance & Corporate Secretary Conference Call Participants Elliot Wilbur - Raymond James Greg Fraser - Truist Securities Brandon Folkes - Cantor Fitzgerald Operator Good day everyone and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter 2022 Earnings Results Call. [Operator Instructions] Please note, this call may be recorded.
- 08/08/2022
|
ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates
- ANI (ANIP) delivered earnings and revenue surprises of 8.33% and 4.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/08/2022
|
Should You Buy ANI Pharmaceuticals (ANIP) Ahead of Earnings?
- ANI Pharmaceuticals (ANIP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 08/04/2022
|
ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Monday, August 8, 2022 Time 8:00 a.m. ET Toll free (
- 07/25/2022
|
What Stocks to Invest Today? 3 Pharmaceutical Stocks To Watch
- Could these pharmaceutical stocks be worth watching today?
- 06/22/2022
|
ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) Date: Tuesday, May 24, 2022 Time: On Demand, 7:00 a.m. ET Webcast: Click Here Jefferies Healthcare Conference (New York City, NY) Date: Thursday, June 9, 2022 Time:
- 05/20/2022
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive Officer Steve Carey - Chief Financial Officer Chris Mutz - Head of Rare Disease Conference Call Participants Elliot Wilbur - Raymond James Brandon Folkes - Cantor Fitzgerald Operator Good day, everyone, and welcome to First Quarter 2022 Call. At this time, all participants are in a listen-only mode.
- 05/10/2022
|
ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates
- ANI (ANIP) delivered earnings and revenue surprises of -250% and 1.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/10/2022
|
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tuesday, May 10, 2022. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date: Tuesday, May 10, 2022 Time: 8:30 a.m. ET Toll free (U.S.): 866-342-8591 Webcast
- 04/19/2022
|
This Pharmaceutical Stock Can Make You Very Rich
- Pharmaceutical stocks are great wealth builders. But you need to discover how to use them and what to avoid.
- 03/26/2022
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
- 03/15/2022
|
ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates
- ANI (ANIP) delivered earnings and revenue surprises of -34.15% and 4.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/15/2022
|
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2021 financial results on Tuesday, March 15, 2022. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Tuesday, March 15, 2022 Time 8:30 a.m. ET Toll free (U.S.) 888-
- 03/07/2022
|
ANI Pharmaceuticals: Back In The Buy Zone
- Today, we revisit specialty pharmaceutical concern ANI Pharmaceuticals for the first time since spring. The company has seen some positive news flow since we last revisited, but the shares of this GARP concern have been held down by the bear market in biotech/biopharma.
- 02/08/2022
|
ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows: Date: Monday, January 10, 2022 On Demand: 7:00 a.m. ET Webcast: https://journey.ct.events/view/5e7687b5-9c3a-4a19-b96c-88ad184d5c59 The webcast will be accessible on demand beginning on January 10, 2022, at 7:00 a.m.
- 01/03/2022
|
Best Momentum Stocks to Buy for January 3rd
- SRTS, ANIP, and AZO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 3, 2022
- 01/03/2022
|
ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021 as follows: Date: Monday, November 22, 2021 Time/On Demand: 10:00 a.m. ET Webcast: https://pipersandler.zoom.us/rec/play/64bSMhpWNru89rAZwgbw_bbk5hNSzXKCBmCoMBP2qXNhF2h83k_wp6c7HmRongJQjr_nHxDjHPMgg4T6.4mLgs_b6
- 11/22/2021
|
ANI Pharmaceuticals reports 3rd Quarter financial results as shares surges
- ANI Pharmaceuticals (NASDAQ: ANIP) recently announced that it recorded $52.1 million net revenues for its third quarter of 2021. However, this was roughly one million dollars less than what they reported in the same quarter of the previous fiscal year.
- 11/01/2021
|
Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
- The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.
- 11/01/2021
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call Transcript
- 11/01/2021
|
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates
- ANI (ANIP) delivered earnings and revenue surprises of 42.25% and 3.50%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/01/2021
|
ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Monday, November 1, 2021 Time 8:30 a.m. ET Toll free (U.S.) 877-8
- 10/29/2021
|
7 Overbought Stocks to Be Very Careful of Right Now
- While the market rally this year has been incredible, worrying developments suggest investors should watch out for overbought stocks. The post 7 Overbought Stocks to Be Very Careful of Right Now appeared first on InvestorPlace.
- 10/01/2021
|
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Virtual Global Healthcare Conference 2021 as follows: Date: Thursday, September 30, 2021 Time: 8:00 a.m. ET Webcast Link: https://wsw.com/webcast/cantor12/anip/2073680 The presentation will be webcast live at the aforementioned time, and archived for 30 days ther
- 09/20/2021
|
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. ANI's Nebivolol Tablets is the generic version of the reference listed drug (“RLD”) Bystolic®. The current annual U.S. market for Bystolic 2.5 mg, 5 mg, 10 mg, and 20 mg strengths is approximately $1.05 billion, according to IQVIA/IMS Health, a leading healthcare data and analytics provider. "The launch of Nebivolol
- 09/17/2021
|
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced that the Company's supplemental New Drug Application (“sNDA”) for Purified Cortrophin® Gel (“Cortrophin Gel”) has been accepted by the U.S. Food and Drug Administration (“FDA”) for review. “FDA's acceptance of our sNDA for Cortrophin Gel marks a significant milestone for ANI. With a PDUFA target action date of October 29, 2021, we are one step closer to bringing a much-needed produ
- 08/31/2021
|
ANI Pharmaceuticals' (ANIP) CEO Nikhil Lalwani on Q2 2021 Results - Earnings Call Transcript
- ANI Pharmaceuticals' (ANIP) CEO Nikhil Lalwani on Q2 2021 Results - Earnings Call Transcript
- 08/06/2021
|
ANI Pharmaceuticals Reports Second Quarter 2021 Results
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2021. Second Quarter and Recent Business Highlights: The Company refiled its supplemental new drug application (“sNDA”) for Cortrophin® Gel with the U.S. Food and Drug Administration (“FDA” or the “Agency”) on June 29, 2021; goal date is October 29, 2021; Acquisition of Novitium Pharma LLC (“Novi
- 08/06/2021
|
Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for
- ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/30/2021
|
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company has re-filed its supplemental new drug application (“sNDA”) for Cortrophin® Gel with the U.S. Food and Drug Administration (“FDA”). “We are delighted to have re-filed our sNDA for Cortrophin Gel in the last week of June. ANI has carefully reviewed every communication from the FDA with our internal subject matter experts and enlisted additional expert advice from i
- 07/06/2021
|
A Low Valuation, High Growth Target: ANI Pharmaceuticals
- ANI's business growth rate could be on the cusp of a rapid acceleration.
- 06/30/2021
|
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows: Date: Tuesday, June 22, 2021 Time: 12:00pm Eastern Time Webcast Link: https://kvgo.com/rj-health/ani-pharmaceuticals-inc-june-2021 The presentation will be webcast live at the aforementioned time, and archiv
- 06/15/2021
|
Post Earnings Assessment On ANI Pharmaceuticals
- ANI Pharmaceuticals posted much better quarterly results than expected on Friday. This triggered a 15% rally in the stock that day, which the shares promptly gave back in yesterday's market sell-off.
- 05/11/2021
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2021 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2021 Results - Earnings Call Transcript
- 05/07/2021
|
ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Top Estimates
- ANI (ANIP) delivered earnings and revenue surprises of 42.47% and 13.59%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2021
|
ANI Pharmaceuticals Reports First Quarter 2021 Results
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three months ended March 31, 2021. First Quarter and Recent Business Highlights: Continued efforts to assemble a robust re-filing package for Cortrophin® Gel in preparation for second-quarter 2021 submission to the U.S. Food and Drug Administration (“FDA”). Signed a definitive agreement to acquire Novitium Pharma LLC (“Novitium”),
- 05/07/2021
|
SNDL Stock Is Need Of a Growth Story and Positive Catalysts
- SNDL stock has fallen considerably from February highs of $4, but it lacks company-specific catalysts for long-term sustainable success. The post SNDL Stock Is Need Of a Growth Story and Positive Catalysts appeared first on InvestorPlace.
- 05/03/2021
|
Earnings Preview: ANI Pharmaceuticals (ANIP) Q1 Earnings Expected to Decline
- ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2021
|
ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ:ANIP) today announced that it has acquired the new drug applications (“NDAs”) for OXISTAT® Lotion, VEREGEN® Ointment, and Pandel® Cream and the abbreviated new drug application (“ANDA”) for ApexiCon® E Cream from Sandoz Inc. Pandel® Cream will be transitioned later upon receiving the requisite approvals. Collectively, these products generated net revenues of $13.2 million in 2020. The acquisition was funded through borr
- 04/06/2021
|
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call Transcript
- 03/09/2021
|
ANI Pharmaceuticals (ANIP) Q4 Earnings Miss Estimates
- ANI (ANIP) delivered earnings and revenue surprises of -20.00% and 3.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 03/09/2021
|
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and 12 months ended December 31, 2020. Corporate Strategy The Company's strategy for sustainable future growth is based on four key pillars: Build a successful Cortrophin franchise; Strengthen the Generics business by enhancing development capabilities and increased focus on niche opportunities. The acquisition of Novitium Ph
- 03/09/2021
|
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including $89.5 million in cash and $74 million in equity plus two potential future cash earn-outs of up to $46.5 million. The transaction has been approved by the ANI
- 03/09/2021
|
ANI Pharmaceuticals's Earnings: A Preview
- ANI Pharmaceuticals (NASDAQ:ANIP) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement.
- 03/08/2021
|
Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline
- ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 03/02/2021
|
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced that ANI's Board of Directors granted non-qualified inducement stock options to purchase an aggregate of 27,006 shares of ANI's common stock to Ori Gutwerg, ANI's Senior Vice President, Generics, and an aggregate of 33,758 shares to Christopher Mutz, ANI's Chief Commercial Officer & Head of Rare Disease, effective February 15, 2021. The stock options were granted as inducement
- 02/19/2021
|
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the addition of three key pharmaceutical executives: Christopher K. Mutz as Chief Commercial Officer and Head of Rare Diseases; Ori Gutwerg as Senior Vice President of Generics; and Davinder Singh as General Manager, Canadian Operations. “We are delighted to welcome Chris, Ori and Davinder to ANI. Their collective experience and individual areas of expertise strengthen our team to
- 02/17/2021
|
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 9, 2021. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Tuesday, March 9, 2021 Time 8:30 a.m. ET Toll free (U.S.) (866)
- 02/16/2021
|
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Food and Drug Administration's (“FDA”) approval of the Company's prior approval supplement application (“PAS”). The current annual U.S. market for Prazosin 1mg and 2mg strengths is approximately $46.2 million, according to IQVIA/IMS Health. "Launch of Prazosin HCl is ANI's fourteenth re-commercialization of a
- 02/01/2021
|
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval and the launch of Aminocaproic Acid Tablets USP, 500mg. The current annual U.S. market for this product is approximately $12.7 million, according to IQVIA/IMS Health. "This is ANI's seventh generic product launch in 2020 and reaffirms our commitment to increasing the pace of market introductions for our products. This important ther
- 12/17/2020
|
ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript
- 11/08/2020
|
ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript
- ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript
- 11/05/2020
|
ANI Pharmaceuticals Reports Third Quarter 2020 Results
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and nine months ended September 30, 2020. Business and Recent Highlights: Company's supplemental New Drug Application (“sNDA”) for lead product, Cortrophin Gel, re-filing on track; driving commercial and operational readiness for a successful launch; Welcomed Nikhil Lalwani as President and CEO, on September 8, 2020; and Broa
- 11/05/2020
|
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results
- BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2020 financial results on Thursday, November 5, 2020, before the opening of the U.S. financial markets. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows: Date Thursday, November 5, 2020 Time
- 10/29/2020
|
ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates
- ANI (ANIP) delivered earnings and revenue surprises of -2.82% and 6.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/06/2020
|
ANI Pharmaceuticals Reports Second Quarter 2020 Results
- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020.
- 08/06/2020
|
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors
- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Officer of SPI Pharma, Inc. and Antonio ("Tony") Pera, former President of Par Pharmaceutical to the ANI Pharmaceuticals Board of Directors. These appointments are effective immediately and increase ANI’s Board of Directors to seven members, including Nikhil Lalwani, who will join the Board next month when he starts as President and CEO of the Company on September 8, 2020.
- 08/06/2020
|
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Offic
- 08/06/2020
|
ANI Pharmaceuticals (NASDAQ:ANIP) PT Lowered to $40.00
- ANI Pharmaceuticals (NASDAQ:ANIP) had its price target cut by investment analysts at Raymond James from $49.00 to $40.00 in a research report issued to clients and investors on Monday, AnalystRatings.com reports. The brokerage currently has an “outperform” rating on the specialty pharmaceutical company’s stock. Raymond James’ price target would indicate a potential upside of 29.41% […]
- 08/05/2020
|
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chief Executive Officer, effective September 8, 2020. Mr. Lalwani will also be elected to the Company’s Board of Directors, effective upon his start date. Mr. Lalwani will succeed Patrick D. Walsh, who will continue to serve as Interim President and CEO until Mr. Lalwani joins the Company and who will remain as Chairman of the Board.
- 08/03/2020
|
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chief
- 08/03/2020
|
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results
- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets.
- 07/30/2020
|
Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to Decline
- ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2020
|
India lodges strong protest with Pakistan High Commission over attempts to convert Lahore gurdwara into mosque
- The gurdwara at Naulakha Bazaar in Lahore is the site of martyrdom of Bhai Taru Singh Ji but has been claimed as the place of Masjid Shahid Ganj, according to the Ministry of External Affairs (MEA) spokesperson Anurag Srivastava.
- 07/27/2020
|
Latest News: 8 Killed After Vehicles Collide in MP’s Chhatarpur
- Catch the latest breaking news and updates here.
- 07/27/2020
|
Covid-19: AIIMS to start human clinical trial of Covaxin from Monday
- Covaxin is being tested in 12 places, according to the Indian Council for Medical Research.
- 07/19/2020
|
Stocks To Watch: Vaccine Players, Earnings Blitz And Fiscal Debate
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
- 07/18/2020
|
32,695 New COVID Cases Take India’s Tally to 9.68 L; Biggest Spike
- Catch all the updates on the coronavirus outbreak here.
- 07/15/2020
|
Meghalaya to Ban Entry Into State; India’s COVID Tally at 9.36 L
- Catch all the updates on the coronavirus outbreak here.
- 07/14/2020
|
Pilot Sacked as Rajasthan Dy CM; Gehlot Says BJP Running the Show
- Catch all the updates on the Rajasthan political crisis here.
- 07/12/2020
|
COVID-19: India Crosses 8-Lakh Mark; Lockdown in Several States
- Catch all the updates on the coronavirus outbreak here.
- 07/10/2020
|
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
- Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
- 07/10/2020
|
26,506 New COVID Cases Take India’s Tally to 7.93 L; Biggest Spike
- Catch all the updates on the coronavirus outbreak here.
- 07/09/2020
|
New Strong Sell Stocks for July 8th
- Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
- 07/08/2020
|
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the acquisition of Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company for $3.0 million. The current annual U.S. market for this product is approximately $40 million, according to IQVIA/IMS Health.
- 07/06/2020
|
Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP)
- Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- 07/05/2020
|
Earthquake tremors felt in Ladakh, Katra region, no damage reported
- The Earthquake of Richter scale 4.5 was reported in 119 km NorthWest of Kargil, Ladakh at 01:11 PM today, a statement issued from the National Centre of Seismology was quoted
- 07/02/2020
|
TMC MP Nusrat Jahan compares TikTok ban to 2016 demonetisation
- The Lok Sabha MP herself had been quite active on TikTok where she interacted with her fans.
- 07/02/2020
|
Tuticorin custodial death case: Police arrest five cops, murder charge added
- Tuticorin custodial death case: P Jeyaraj and his son Bennicks were arrested for violating lockdown norms over business hours of their cellphone shop. They died at a hospital in Kovilpatti on June 23.
- 07/02/2020
|
Shortage of labourers hit paddy farming in Amritsar
- Farmers in Amritsar are facing problems in paddy plantation due to shortage of labour, following mass exodus of migrant labourers across the country due to COVID-19 pandemic.
- 07/02/2020
|
Nepal PM Oli gets President nod to prorogue Parliament amid calls for his resignation
- While the prorogation of the Parliament will save Oli from an immediate floor test, it will also allow him to bring an ordinance to relax the provision of party split, which he had initially brought up in April while he was facing criticism for his handling of the country's Covid-19 situation.
- 07/02/2020
|
Banning 59 Chinese apps was 'digital strike', move to protect data of Indians: Ravi Shankar Prasad
- India on June 29 banned 59 Chinese apps, including TikTok, Shareit, UC Browser and Xiaomi’s Mi Community over national security concerns.
- 07/02/2020
|
Chinese apps ban: TikTok's parent company may lose $6 Billion
- China-based ByteDance could face a loss of USD 6 Billion following the Indian government's decision to ban 59 Chinese apps including wildly popular TikTok.
- 07/02/2020
|
Nepal PM Oli meets President amid demand for resignation, will address nation today
- As calls for his resignation grow louder, Nepal Prime Minister KP Sharma Oli is expected to address the nation today. The Nepal PM earlier met President, followed by a meeting with the Cabinet.
- 07/02/2020
|
Centre launching personal attacks as Priyanka Gandhi Vadra raises voice for people, poor: UP Cong chief
- Condemning Centre's orders asking Congress General Secretary Priyanka Gandhi Vadra to vacate her government accommodation in New Delhi, Uttar Pradesh Congress chief Ajay Kumar Lallu on Thursday said that the Union government is launching personal attacks on the Congress leader as she is continuously raising voice for the rights of people and poor.
- 07/02/2020
|
No difference of opinion with Ayush ministry, says Ramdev’s Patanjali
- The ministry, in a letter to Patanjali, said: “It may be ensured that on the package and label displayed on the medicines, no claim for the cure of Covid-19 should be mentioned.”
- 07/02/2020
|
After Mukul Rohatgi, Abhishek Manu Singhvi also refuses to appear for TikTok
- On June 29, the Government of India banned 59 Chinese apps saying they were posing threats to security of the country. Some of the apps like TikTok and ShareIt were highly popular in India.
- 07/01/2020
|
PM Modi hits delete on his Weibo account after banning it in India. It isn’t easy
- New Delhi had initially tried to delete PM Modi’s account but it turned out that the Chinese social media platform had a “complex procedure” for VIP accounts, people familiar with the development said.
- 07/01/2020
|
IPL 2020: No date decided yet, BCCI solving issues before meeting to discuss league’s fate this year
- Cancellation or postponement of the World T20 will certainly open a window for the BCCI to host the IPL 2020.
- 07/01/2020
|
Ganeshotsav in Mumbai: Labaughcha Raja Mandal cancels grand Ganpati celebrations; Check their plan
- This year, the Ganeshotsav celebrations would be at a much subdued level due to the pandemic.
- 07/01/2020
|
Mukul Rohatgi refuses to appear for TikTok against Government of India
- Mukul Rohatgi's remark comes just two days after India blocked 59 Chinese apps including the ones like TikTok and ShareIt that were very popular among the young population.
- 07/01/2020
|
PM Modi quits Chinese social media website Weibo; Profile picture, posts taken down
- After the government had announced a ban on 59 Chinese apps, Prime Minister Narendra Modi has decided to quit the Chinese microblogging website Weibo, which he had joined a few years ago.
- 07/01/2020
|
India, China prioritise phased, stepwise de-escalation in commander level talks
- This was third senior military commander level engagement in Chushul held to discuss issues related to disengagement at the faceoff sites along the LAC and de-escalation from the border areas
- 07/01/2020
|
India, China prioritise phased, stepwise de-escalation in 3rd Corp-Commander level talks
- India and China have emphasised the need for an expeditious, phased and stepwise de-escalation of tension along the Line of Actual Control "as a priority" during the third commander level talks between the People's Liberation Army and Indian Army held at Chushul, Ladakh, on June 30, sources privy to the matter told ANI on Wednesday.
- 07/01/2020
|
Nusrat Jahan on TikTok ban: People will suffer like demonetisation
- Nusrat Jahan said she doesn't have a problem with the ban on Chinese apps but wants to know the "strategic plan" behind it.
- 07/01/2020
|
Sisodia vs Shah over Covid-19: Will July actually be worse for Delhi?
- Delhi has witnessed surge in coronavirus numbers throughout June. Will July be worse? Manish Sisodia in mid-June projected the number at 5.5 lakh which Amit Shah thought created fear among people.
- 07/01/2020
|
BCCI's decision about Chinese sponsorship in IPL to be taken in 'best interest of country'
- BCCI gets Rs 440 crore annually from Chinese mobile brand Vivo – the principal sponsor of the cash-rich IPL – in a five-year deal that ends in 2022.
- 07/01/2020
|
No date decided for the IPL 2020 review meeting yet: BCCI sources
- Amid the rising speculations over the fate of Indian Premier League (IPL) 2020, BCCI sources told ANI on Wednesday (July 1) that no date has been decided for the IPL review meeting so far, adding that there are issues that BCCI is looking into before finalising the date. Sources said that the IPL review meeting will take place once the BCCI offiicals will work on all the surrounding issues of IPL.
- 07/01/2020
|
17 injured as boiler explodes at Neyveli lignite plant in Tamil Nadu
- At least 17 people got injured in an explosion at a boiler in Unit 5 of plant 2 of the Neyveli lignite plant in Tamil Nadu, ANi reported. The injured were admitted to NLC lignite hospital and rescue operations are still underway at the lignite plant. This is the second blast in the last two months at the plant.
- 07/01/2020
|
Kerala’s first visually impaired student to write class 10th exam using computer, scores A plus in all subjects
- Haroon Kareem’s fight to secure permission to use computers instead of the conventional scribe system was reported by ANI, following which state Education Minister C Raveendranath had issued a special order to permit him to take SSLC examination on computer.
- 07/01/2020
|
Assam floods: Over 14 lakh affected in 23 districts
- At present, 25,461 people are staying in 265 relief camps, said officials.
- 07/01/2020
|
Kerala SSLC Result: Haroon T K, a visually impaired student scores A plus in all subjects - Times of India
- Education News: Haroon'following which state Education Minister C Raveendranath had issued a special order to permit him to take SSLC examination on computer.
- 07/01/2020
|
Over 14 lakh affected in 23 districts of Assam due to floods, death toll climbs to 27
- Over a million people have been affected in 23 districts of Assam due to floods, state Disaster Management Authority informed on Tuesday (June 30). According to the Assam State Disaster Management Authority, a population of 14,93,508 affected in 23 districts of Assam due to floods in the state. The death toll stands at 27 after three new deaths were reported in Barpeta (2) and Dibrugarh (1) districts on June 30.
- 07/01/2020
|
Patanjali’s Coronil: Did not say medicine can cure or control coronavirus, says Acharya Balakrishna
- Coronil had been launched by the Baba-Ramdev owned Ayurveda consumer goods company on June 23 this year.
- 06/30/2020
|
Clip Showing Bodies of Covid Victims Being Dumped in Pit in K'taka Triggers Outrage, Staff Suspended
- In the video, workers in PPE are seen bringing bodies in black sheets from a vehicle parked nearby and dropping one after another into the large pit, dug up with the help of an earthmover.
- 06/30/2020
|
Bodies Of COVID-19 Victims Tossed Into Mass Grave In Karnataka
- Eight bodies - believed to be of those killed by the COVID-19 virus - wrapped in plastic are being tossed into a common pit for burial in a disturbing video that emerged Tuesday from Karnataka's Ballari district
- 06/30/2020
|
Centre Says Patanjali Can't Sell Coronil with Claims of Curing Covid-19, Approves it as Immunity Booster
- The Uttarakhand AYUSH Department has given Coronil approval as an immunity booster and has given it the license to make three medicines and has allowed clinical trial under the rules.
- 06/30/2020
|
China responds to India’s ban on TikTok, other apps; says India must be responsible
- Chinese Foreign Ministry spokesperson Zhao Lijian underlined that the Chinese government always asks Chinese businesses to abide by international and local laws-regulations.
- 06/30/2020
|
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million, according to IQVIA/IMS Health.
- 06/30/2020
|
Mumbai's Taj Hotel receives bomb threat, call traced to Pakistan
- Mumbai’s Taj Hotel has received a bomb threat call from Pakistan.Police forces have tightened security around Mumbai’s Taj Hotel
- 06/30/2020
|
Amit Shah, S Jaishankar, Piyush Goyal meet amid standoff
- The meeting was held without officials, amid the standoff with China and the Covid-19 pandemic. Details were not known. The Indo-Tibetan Border Police and the Seema Suraksha Bal, who patrol boundaries with China and Nepal, fall under the home ministry. The presence of commerce minister Goyal amid campaign for boycott of Chinese products created a buzz.
- 06/30/2020
|
Ashiesh Roy to Solanki Diwakar: How Pandemic Forced Actors in Blockbusters to Penury
- Solanki Diwakar, who started selling fruits to meet the needs of his family. Diwakar has shared screen with Ayushmann Khurrana and Anuu Kapoor in the film 'Dream Girl'.
- 06/30/2020
|
News updates from Hindustan Times: New influenza virus G4 discovered in China, scientists say it can trigger pandemic and all the latest news
- Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
- 06/30/2020
|
Market LIVE: Sensex pares gains, nears day's low
- Barring Nifty pharma and media, all sectoral indices rose.Tata Steel, ICICI Bank, NTPC led gains on Sensex
- 06/30/2020
|
Gas leak at pharma company in Visakhapatnam, 2 dead, four hospitalised | LIVE
- At least two people were killed and four were hospitalised after a Benzimidazole gas leak at a pharmaceutical unit in Andhra Pradesh's Vishakhapatnam, news agency ANI reported. The situation is reportedly under control now.
- 06/30/2020
|
2 workers die, 4 hospitalised after gas leak in Visakhapatnam factory: Report
- The leakage of benzimidazole gas was reported from Sainor Life Sciences Pvt Ltd in Visakhapatnam, according to the news agency.
- 06/30/2020
|
ANI Pharmaceuticals: Significantly Undervalued
- ANI Pharmaceuticals, Inc. (ANIP) has seen its shares crater over 60% in the past ten months with disappointing results and the sudden departure of its eleven-ye
- 06/29/2020
|
Delhi opens 10,000-bed coronavirus care facility as cases rise
- NEW DELHI - Delhi has set up one of the world's largest Covid-19 care facilities, hoping to reinforce its loosening grip on a worrying outbreak of the disease in the city.. Read more at straitstimes.com.
- 06/29/2020
|
Javed Hydar to Solanki Diwakar: How Pandemic Forced Actors in Blockbusters to Penury
- Javed Hydar has acted in films like Baabarr (2009), Ghulam (1998) and Life Ki Aisi Ki Taisi (2017), but is now selling vegetables to meet ends.
- 06/29/2020
|
Syed Ali Shah Geelani, Kashmiri separatist leader, resigns from Hurriyat Conference
- Kashmir separatist leader Syed Ali Shah Geelani has resigned from the All Parties Hurriyat Conference.
- 06/29/2020
|
India-China clash: Rafale jets with Meteor missiles to arrive next month
- Rafale jets to arrive by next month: The first Rafale-Meteor aircraft will be flown by the Commanding Officer of the 17 Golden Arrows squadron with a French pilot
- 06/29/2020
|
Manish Sisodia hails Centre's role in Delhi's fight against Coronavirus, dubs support as 'tremendous'
- The national capital is the second worst hit state with a total of 83,077 Coronavirus cases, including 2,623 deaths and 52,607 recoveries.
- 06/29/2020
|
What Manish Sisodia Said After Amit Shah Said His Comment "Created Fear"
- Delhi Chief Minister Arvind Kejriwal believes that the capital's battle against coronavirus is very big and that no one person or agency can deal with it alone, Deputy Chief Minister Manish Sisodia said on Sunday after Union Home Minister Amit Shah hit out at Mr Sisodia over the estimation that there will be 5.5 lakh COVID-19 cases in Delhi by July 31.
- 06/29/2020
|
Had to step in because Sisodia’s statement on spike caused panic: Amit Shah
- On Sunday, Delhi's case load was 80,188, of which 28,329 were active cases. Over 2,500 people have died so far, but nearly 50,000 have recovered, according to Union Health Ministry data.
- 06/28/2020
|
Another COVID-19 lockdown in Hyderabad? Telangana CM asks govt machinery to ‘be ready’
- COVID-19 lockdown in Hyderabad: With a single-day high of 1,087 new COVID-19 cases reported on Saturday, the tally of Coronavirus cases in Telangana had risen to 13,436.
- 06/28/2020
|
'He is speaking goons' language': Chhattisgarh CM on Amit Shah 'do-do haath ho jayein' remark
- He was referring to Amit Shah's statement challenging Rahul Gandhi for a debate in Parliament on Indo-China conflict since 1962.
- 06/28/2020
|
No community transmission in Delhi, Manish Sisodia’s ‘5.5 lakh COVID-19 cases by July 31’ remark created panic: Amit Shah
- COVID-19 cases in the national capital has crossed the 80,000-mark, however, Amit Shah said there was not need to worry as things were under control.
- 06/28/2020
|
Boycott China Call: Bihar cancels tender of mega bridge project involving Chinese companies
- Bihar government has decided to cancel the contract for construction of an important bridge, awarded to Chinese companies, said a news agency.
- 06/28/2020
|
PM CARES Fund received money from Chinese companies: AM Singhvi
- In the latest round, the Congress has accused the BJP of dodging questions over national security.
- 06/28/2020
|
'Irony at its peak': Rainwater enters residence of Bihar Road Construction Minister; Twitter says it's 'karma'
- Notably, the incessant rainfall is continuing even two days after continual thunder and lightning strikes killed more than 90 people and injured several in different parts of Bihar.
- 06/28/2020
|
30,000 Covid-19 beds will be available in Delhi by June-end: Amit Shah
- Shah also said rates of isolation beds which were around ₹24,000 and ₹25,000, have been reduced to ₹8,000 to ₹10,000.He also disagreed with Delhi's Deputy CM Manish Sisodia and said Delhi will not have 5.5 Lakh cases by July-end
- 06/28/2020
|
Amit Shah Slams Rahul Gandhi's 'Shallow' Politics Amid China Standoff, Says Prepared for Parl Debate
- Shah said that the government was fully capable of handling anti-India propaganda but it was painful when a former president of such a big political party indulges in shallow-minded politics at a time of crisis.
- 06/28/2020
|
Mumbai: Salons, barber shops, beauty parlours reopen after over three months, allowed with restrictions
- Maharashtra continues to be the epicenter of the coronavirus spread
- 06/28/2020
|
We have planned in advance, 30,000 COVID-19 beds in Delhi by end of June: Amit Shah
- Amit Shah said rates of isolation beds which were Rs 24,000 to Rs 25,000 earlier have been reduced to Rs 8000 to Rs 10,000.
- 06/28/2020
|
No Community Transmission in Delhi, Assures Amit Shah, Says Manish Sisodia's Claim of 5.5L Cases Led to Fear
- The minister also said a series of steps had been taken to contain the virus and multi-agency meetings had been held to improve coordination at various levels, stressing that Delhi Chief Minister Arvind Kejriwal was in the loop about all efforts.
- 06/28/2020
|
Rahul Gandhi's 'shallow-minded politics' is being liked by China and Pakistan: Amit Shah
- In an interview with news agency ANI, Home Minister Amit Shah said that Rahul Gandhi should introspect if his hashtag of 'Surender Modi' is being encouraged by Pakistan and China.
- 06/28/2020
|
No COVID-19 community transmission in Delhi, won't let cases touch 5.5 lakh in July: Amit Shah
- Union Home Minister Amit Shah has assured the people of Delhi that there is no community transmission in the national capital as of now. In an interview given to news agency ANI, Amit Shah has said that he has spoken to experts who have assured him that Delhi's situation is not that bad and no community transmission is taking place.
- 06/28/2020
|
Barber shops, beauty parlours open in Maharashtra from today
- As per the govt order only select services like hair cut and dyeing, waxing and threading are allowed .Barbers must put protective gear, including gloves, aprons and masks. All workspace (chairs) must be sanitised after each service, the govt order said
- 06/28/2020
|
Salons Reopen In Maharashtra After Over 3 Months
- Hair salons in Maharashtra reopened today, after over three months of downing shutters due to the coronavirus-induced lockdown.
- 06/28/2020
|
PV Narasimha Rao Birth Anniversary: All You Need to Know About the Former Indian Prime Minister
- PV Narasimha Rao or Pamulaparti Venkata Narasimha Rao is best known for introducing sweeping economic reforms that liberalised the Indian economy.
- 06/28/2020
|
Liu Chuen Chen
- Senior Sub-Editor with The Indian Express, online. The author tweets at @chuenchenliu
- 06/27/2020
|
Pakistan Trying to Create 'Mirage of Goodwill' with Offer to Reopen Kartarpur Corridor on Monday, Say Sources
- India's response came hours after Pakistan conveyed its readiness to reopen the corridor on Monday more than three months after it was temporarily closed due to the COVID-19 pandemic.
- 06/27/2020
|
‘Nightmare’: Called to remove a snake from bathroom, rescuer finds venomous viper birthing 35 snakelets!
- Realising that the snake had been giving birth to snakelets, rescuer Murali kept the bag under a tree. Two hours later, he found 35 snakelets.
- 06/27/2020
|
India-China row: Indian armed forces move air defence missile systems into Ladakh sector
- The deployment of the advanced quick-reaction surface-to-air missile defence systems comes after the Chinese side reportedly increased fighter aircraft and helicopter activities along the Line of Actual Control (LAC) in the past few days
- 06/27/2020
|
‘Shut your windows’: Delhi advises people as locusts enter Delhi from Gurugram
- District magistrates have been asked to deploy adequate staff to guide villagers and residents to distract the locusts by making loud noise by beating drums/utensils, bursting crackers, burning Neem leaves and other similar measures.
- 06/27/2020
|
'Attempt to create mirage of goodwill': India on Pak decision to reopen Kartarpur Corridor amid Coronavirus
- Pakistan in July last year agreed in-principle to build a bridge on the zero line of the Kartarpur Corridor to provide all-weather connectivity.
- 06/27/2020
|
Surge In Diesel Prices Make Vegetables, Fruits Costlier In Delhi
- Continuous increase in fuel prices has affected the sale of vegetables and fruits in the national capital. Transporters told news agency ANI that due to the increase in the prices of petrol and diesel, the transportation cost has been also been hiked, subsequently making the food products costlier for the consumers.
- 06/27/2020
|
Enforcement Directorate Questions Ahmed Patel Over Money Laundering Case
- The Enforcement Directorate questioned senior Congress leader Ahmed Patel on Saturday in connection with a multi-crore money laundering case involving Gujarat-based firm Sterling Biotech and the main promoters of the Sterling Group - the Sandesara brothers.
- 06/27/2020
|
This village in Pune has passed resolution to ban Chinese products
- The resolution was passed by the members of Gram panchayat in their annual meeting earlier.
- 06/27/2020
|
Coronavirus India Live Updates: COVID-19 Cases In India Cross 5-Lakh Mark
- Coronavirus Live Updates: India's total of coronavirus cases crossed the five lakh-mark on Friday after the country reported its highest single-day spike of over 17,000 cases. Maharashtra, the worst-hit state, with over 5,000 new cases, reached an aggregate of 1,52,765, while West Bengal and Tamil Nadu also reported their biggest single day COVID-19 numbers.
- 06/26/2020
|
When will Delhi schools reopen? Deputy CM Manish Sisodia says this
- A number of government schools in Delhi have been turned into COVID-19 quarantine centres and shelter homes for migrant workers.
- 06/26/2020
|
Coronairus outbreak: PM Modi praises CM Yogi-led UP govt; Here’s what he said
- Addressing the launch of ‘Atma Nirbhar Uttar Pradesh Rojgar Abhiyan,’ Prime Minister Narendra Modi praised the work of Uttar Pradesh government and said that the state’s hard work during the Coronavirus pandemic has saved the lives of 85,000 people.
- 06/26/2020
|
West Bengal HSC Exam cancelled! Next date for Class 12 exams to be announced later
- West Bengal Higher secondary exam which was supposed to be conducted on 2nd, 6th and 8th July has been cancelled, next date will be announced later, State Education Minister Partha Chatterjee said. (To be continued)
- 06/26/2020
|
Warner Bros move release of Nolan's Tenet to August 12
- The release of Christopher Nolan-directed espionage thriller Tenet has moved from July 31 to August 12.
- 06/26/2020
|
People of PoK, Giglit Baltistan stand with Indian Army in fight against China, says activist
- A political activist from Pakistan occupied Kashmir (PoK), who is living in exile in Glasgow, has expressed his anger over Chinese aggression at the Line of Actual Control in Ladakh and pledged to support the Indian Army.
- 06/26/2020
|
Karnataka 10-Year-Old, Born With One Hand, Stitches Masks For Students
- A 10-year-old girl from Karnataka has emerged as an achiever amid the coronavirus pandemic. Sindhuri, a Class 6 student from Udupi district, stitched as many as 15 masks only with her right hand as the left hand, below the elbow, is not there since birth. Masks are mandatory for all as a precautionary measure against COVID-19.
- 06/26/2020
|
Hyderabad’s Begum Bazar to remain under voluntary lockdown from June 28 to July 5
- Hyderabad Kirana Merchant Association’s president said the decision was taken for the safety of all the merchants, customers, staff and residents staying in the commercial market zone in view of the Covid-19 situation.
- 06/26/2020
|
Hyderabad's Begum Bazar to remain under voluntary lockdown between June 28 to July 5
- In wake of the COVID-19 pandemic, the Hyderabad Kirana Merchants Association has voluntarily announced the lockdown of shops at Begum Bazar from June 28 to July 5.
- 06/25/2020
|
COVID-19: Hetero releases generic Remdesivir ‘Covifor’, check cost per injection
- Last week, Hetero had announced that it was granted manufacturing and marketing approval for its generic drug from the Drug Controller General of India (DGCI).
- 06/25/2020
|
Henry Cavill hopes to continue playing Superman for years to come
- English actor Henry Cavill hopes to continue playing Superman for years to come.
- 06/25/2020
|
COVID-19: States being delivered generic version of Remdesivir, 20 thousand vials ready costing Rs 5400 per injection, says Hetero - Times of India
- Domestic pharma giant Hetero has started delivering the generic version of 20,000 vials of Covifor (Remdesivir) across the country. The product is pri
- 06/25/2020
|
China moves back some troops, vehicles to depth areas in Galwan Valley: Report
- Chinese side had given assurance on June 22 that they will move back troops from the front to the depth areas, sources said.
- 06/25/2020
|
Tourism industry in Shimla prepares for Covid-19 unlock, Himachal Pradesh witnesses rains
- Amid easing of lockdown restrictions, the tourism industry is preparing for the containment of COVID-19 in Shimla.
- 06/25/2020
|
COVID-19: States being delivered generic version of Remdesivir, 20 thousand vials ready costing Rs 5400 per injection, says Hetero
- Domestic pharma giant Hetero has started delivering the generic version of 20,000 vials of Covifor (Remdesivir) across the country. The product is priced at Rs 5,400/- per vial.
- 06/25/2020
|
Social distancing goes for toss as RJD leaders protest fuel hike
- As fuel prices skyrocket across the country, Rashtriya Janata Dal (RJD) leaders Tejashwi Yadav and Tej Pratap Yadav along with other party cadres were seen riding bicycles as a mark of protest on the streets of Patna on Thursday.
- 06/25/2020
|
Monsoon Arrives In Delhi, Covers Entire UP, Announces Met Office
- Monsoon 2020: There is good news for people in Delhi. The met office said monsoon has officially arrived in the city. Monsoon has covered the entire Uttar Pradesh, parts of Haryana, Punjab and Rajasthan
- 06/25/2020
|
Lockdown should be implemented properly in West Bengal: Dilip Ghosh
- West Bengal BJP president Dilip Ghosh has said that lockdown should be implemented properly in the state.
- 06/25/2020
|
Tourism industry in Shimla prepares for COVID-19 unlock
- Amid easing of lockdown restrictions, the tourism industry is preparing for the containment of COVID-19 in Shimla.
- 06/25/2020
|
Nonprofits Insurance Alliance (NIA) Joins Federal Home Loan Bank of Boston
- Nonprofits Insurance Alliance (NIA), the leading P&C insurance provider exclusively serving the 501(c)(3) nonprofit sector, announced today that A
- 06/25/2020
|
Patanjali’s ‘breakthrough’ needs vetting, say experts
- The principal investigator running the clinical trial at a Jaipur medical college confirmed the findings but said they were preliminary and the study, ongoing.
- 06/24/2020
|
Patanjali Coronil: Uttarakhand Ayurved dept clarifies licensing order to Baba Ramdev’s firm
- The ministry had halted the advertisement by Patanjali for its Coronil which they have claimed can cure coronavirus infection in seven days. The Ministry said the drug would have to be checked first before it is marketed.
- 06/24/2020
|
Uttarakhand Ayurved dept issues notice to Patanjali for developing COVID medicines
- A notice has been issued to yoga guru Ramdev's Patanjali Ayurved asking how it got permission to make the Ayurvedic formulation for treating COVID-19, said YS Rawat Licence Officer, Uttarakhand Ayurved Department on Wednesday.
- 06/24/2020
|
Coronavirus treatment: Here’s what AYUSH Minister said on Patanjali’s Coronil, Swasari Vati, Anu Taila
- Baba Ramdev Patanjali Coronavirus Covid-19 Vaccine Coronavirus Medicine India Latest News Update Today Corona Medicine vaccine
- 06/24/2020
|
Coronil application 'didn't mention coronavirus'; Patanjali says 'everything is in order'
- While launching the drug yesterday, Patanjali had said:
- 06/24/2020
|
AAP MLA Prakash Jarwal arrested in connection with doctor’s suicide gets bail
- Prakash jarwal and his aide wee arrested after they failed to join the investigation even after the police sent them notices.
- 06/24/2020
|
Patanjali didn’t mention Covid-19 drug in license application: Uttarakhand official
- The AYUSH ministry said on Tuesday that it has requested the licensing authority of Uttarakhand government to provide copies of the license and product approval details of the Ayurvedic medicines being claimed for the treatment of Covid-19.
- 06/24/2020
|
Patanjali’s Coronil approval application did not mention coronavirus: Licence officer
- A licencing officer from the Uttarakhand government's Ayurved department said Patanjali's Coronil licensing application had no mention of coronavirus. On the contrary, Ramdev had earlier said all permissions were taken.
- 06/24/2020
|
Boycott China: Indian community protests outside Chinese consulate in Canada
- Indian community in Canada held an anti-China protest on Wednesday after a deadly border clash led to the death of 20 Indian soldiers. Many people in the country have called for boycotting Chinese goods after the incident.
- 06/24/2020
|
China Encroaches Upon At least 10 Places in Nepal by Diverting Rivers Through Construction in Tibet: Report
- The document has warned that Nepal would lose more lands if proper steps are not taken in time.
- 06/24/2020
|
Rajnath Singh to not meet Chinese Defence Minister Wei Fenghe in Moscow
- The development comes after Chinese media reported that Singh will meet his Chinese counterpart amid the border tensions between New Delhi and Beijing
- 06/24/2020
|
Amid border tensions, India, China likely to hold joint secretary-level talks on June 24
- The Working Mechanism for Consultation and Coordination on India-China Border Affairs (WMCC) is likely to hold virtual meet on Wednesday to discuss border tensions between the two countries.
- 06/24/2020
|
India denies Chinese media report of meeting between Rajnath Singh and his counterpart Wei Fenghe
- Union Defence Minister Rajnath Singh will not meet his Chinese counterpart Wei Fenghe on the sidelines of grand Victory Day parade in Moscow on Wednesday (June 24), ANI reported on Tuesday (June 23). It is to be noted that Global Times, the Chinese mouthpiece, had reported about the possibility of such a meeting between the two leaders in Russian capital.
- 06/24/2020
|
India, China likely to hold joint secretary-level talks on Wednesday amid border tensions
- India and China held Corps Commander-level talks on Monday in which both sides reached a mutual consensus to disengage in the Eastern Ladakh sector.
- 06/23/2020
|
IMD records cyclonic circulations over Odisha! Check details
- Some cyclonic circulations have been recorded over the interior Odisha and its neighbourhood.
- 06/23/2020
|
Fact Check: Is Bank of China opening its first branch in India amid border tensions?
- A viral post on social media claims that the RBI has given a license to the Bank of China to operate in India amid border tensions between the two countries.
- 06/23/2020
|
Ganpati festival in Mumbai: Subdued celebrations this year; all you need to know
- Maharashtra is the worst-affected state in the country by the pandemic, with over 1.35 lakh cases.
- 06/23/2020
|
Arvind Kejriwal writes to Amit Shah on Covid-19. Gets a blunt response on Twitter
- Amit Shah tweeted a sharp response to Kejriwal within hours, pointing that he had issued instructions for deploying doctors from the ITBP three days back.
- 06/23/2020
|
Baba Ramdev’s Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know
- Coronavirus-induced COVID-19 has caused a global pandemic, due to which the number of cases all over the world have reached nearly 90 lakh.
- 06/23/2020
|
Mumbai fire: Massive blaze breaks out at Kurla scrap godown in Mandala, fire-fighting operation underway
- Kurla scrap godown, Mumbai fire today: Fire breaks out at a scrap godown in Kurla on Tuesday morning.
- 06/23/2020
|
Swami Ramdev led Patanjali launches Ayurvedic medicine Coronil to fight coronavirus: All you need to know
- Swami Ramdev led Patanjali has launched an Ayurvedic medicine Coronil, which claims to treat coronavirus. Patanjali Ayurved Limited MD Acharya Balkrishna had announced on Twitter that the company has found a medicine for coronavirus.
- 06/23/2020
|
Imran Khan backs PCB to criminalise match-fixing
- The Pakistan Cricket Board has Prime Minister Imran Khan's backing to criminalise match-fixing, PCB chairman Ehsan Mani has confirmed.
- 06/23/2020
|
Odisha: Puri prepares to hold Lord Jagannath’s Rath Yatra
- To contain the spread of Covid-19, authorities in Odisha have imposed restriction of movement starting from Monday 9 pm to Wednesday 2 pm.
- 06/23/2020
|
COVID-19 Unlock: Kamakhya Devi temple set to open from June 30, annual Ambubachi Mela canceled this year
- Even before the nationwide lockdown was imposed the temple administration had been shut for the fear of Coronavirus pandemic.
- 06/22/2020
|
Saudi Arabia to hold haj with very limited numbers for all nationalities living inside kingdom
- Read more about Saudi Arabia to hold haj with very limited numbers for all nationalities living inside kingdom on Devdiscourse
- 06/22/2020
|
COVID-19: Kudos! Kerala engineering student develops automatic thermal scanner to record temperature along with photo
|
Mild earthquake of 3.6 magnitude rattles Jagdalpur in Chhattisgarh
- It was the second instance of an earthquake in India in around 12 hours and the third since Sunday.
- 06/22/2020
|
China didn't lose more soldiers than India, Indian officials giving out wrong numbers: Chinese state media
- Indian officials are giving wrong numbers just to satisfy hardliners by claiming that China lost more soldiers than India, Global Times said.
- 06/22/2020
|
Sushant Singh Rajput’s financial condition was good, ex-manager shares break-up of his monthly expenses
- Sushant Singh Rajput's monthly expenditure was close to Rs 10 lakh. The rent for his apartment in Bandra was Rs 4.5 lakh per month. The actor had also rented a farmhouse near Pavana Dam, Lonavla, for which he paid several lakhs.
- 06/22/2020
|
India-China Faceoff: Traders hold protest in Delhi's Karol Bagh, burn Chinese goods
- Members of the Confederation of All India Traders (CAIT) burn Chinese goods in Karol Bagh to protest against the killing of 20 Indian soldiers in clashes with the Chinese troops in the Galwan Valley last week.
- 06/22/2020
|
UP BEd JEE 2020 exam date released: Check details here
- UP BEd JEE 2020 exam is now scheduled to be held on July 29, 2020.
- 06/22/2020
|
COVID-19: Medical college in J-K's Rajouri to soon have new building
- The work on constructing a new building of Government Medical College (GMC) in Rajouri district of Jammu and Kashmir is being done on war footing amid COVID-19 pandemic.
- 06/22/2020
|
Coronavirus India Live News Update: 57 Girls At Government-Run Home In UP's Kanpur Test Positive
- Fifty-seven girls who live at a government-run shelter in Uttar Pradesh's Kanpur have tested positive for the novel coronavirus in the past week. This means the institution is now a COVID-19 cluster in a town already battling a high caseload.
- 06/22/2020
|
Delhi Police arrest 4 for attacking retired MEA official, murdering wife in robbery bid
- Aged 94, retired MEA official BR Chawla and his wife Kanta Chawla lived on an upper ground floor apartment in Delhi's Safdarjung Enclave.
- 06/21/2020
|
Tamil Nadu reports highest single-day spike in Covid-19 cases, tally nears 60,000
- The Tamil Nadu government has extended lockdown in four districts to curb a surge in the number of Covid-19 positive cases.
- 06/21/2020
|
Surya Grahan 2020: Badrinath Temple Opens Its Doors After Eclipse
- Surya Grahan 2020: Ahead of the solar eclipse, doors of all four Chardham temples in Uttarakhand - Badrinath, Kedarnath, Gangotri and Yamunotri - were shut at 10 pm Saturday night.
- 06/21/2020
|
India-China Standoff: Defence forces granted special powers to buy critical weapons upto Rs 500 crore
- Similar financial powers were given to the armed forces after the Uri attack and the Balakot aerial strikes against Pakistan. The requirement of granting this power again to the forces was felt by the government after the Chinese aggression in Eastern Ladakh along the Line of Actual Control (LAC).
- 06/21/2020
|
Coronavirus Highlights (June 20): Glenmark launches COVID medicine FabiFlu, Delhi records highest spike
- Coronavirus Unlock 2.0 news, satyendra jain plasma therapy, corona cases in india, lockdown india, india news, coronavirus news, covid 19 india, coronavirus live news, corona news, corona latest news, india coronavirus, coronavirus live news, coronavirus latest news in india, coronavirus live update
- 06/21/2020
|
Social Media Ablaze with Photos after Rare 'Ring of Fire' Solar Eclipse Spotted in India
- 'Ring of Fire' solar eclipse occurs when the moon fails to completely obscure sunlight, resulting in a slivery glowing ring to appear as an outline to the otherwise darkened sun.
- 06/21/2020
|
V Hanumanth Rao tests positive for COVID-19 in Hyderabad
- Senior Congress Leader and former Pradesh Congress Committee (PCC) president V Hanumanth Rao has tested positive for COVID-19.
- 06/21/2020
|
Hyderabad: Congress leader V Hanumantha Rao tests positive for COVID-19
- The 72-year-old senior Congress leader confirmed this development and said that he had started to feel sick shortly after his birthday.
- 06/21/2020
|
India-China face-off: People in Jammu buy ''Boycott China'' face masks
- People were seen buying indigenously manufactured `Boycott China` face masks to fight coronavirus.
- 06/21/2020
|
Solar Eclipse 2020: Images of the celestial event from around the country. They’re mesmerising
- Solar Eclipse 2020: With this annular solar eclipse going on, Twitter is abuzz with with posts related to this amazing celestial event.
- 06/21/2020
|
3 Terrorists, Holed Up Inside House, Killed In Srinagar Encounter
- Three terrorists have been killed by security forces in Zadibal Soura area of Srinagar, police said. The terrorists wereholed up inside a house in the area, police said, adding that terrorists have refused to an offer to surrender.
- 06/21/2020
|
Solar Eclipse 2020 Live Updates: "Ring Of Fire" Visible From Parts Of India
- The annular solar eclipse, popularly known as the "ring of fire" eclipse, has become visible in India, with social media flooded with pictures from the rare celestial event. This is the first solar eclipse of 2020. Skywatchers living within a narrow band covering parts of Rajasthan, Haryana, and Uttarakhand will be able to see the "ring of fire" with much clarity.
- 06/21/2020
|
International Yoga Day 2020: See In Pics How It Is Being Observed
- International Yoga Day 2020: Prime Minister Narendra Modi, who played an instrumental role in popularizing yoga in the world after coming to power in 2014, said in his message today. Since 2015, International Yoga Day, is a United Nations designated day.
- 06/21/2020
|
Indo-Tibetan Border Police Personnel Perform Yoga In Sub-Zero Temperature
- Amid snow-white mountain peaks and sub-zero temperatures of Ladakh, the soldiers of the Indo-Tibetan Border Police (ITBP) performed yoga asanas at an altitude of 18,000 feet to markthe International Yoga Day.
- 06/21/2020
|
Cipla, Hetero get nod to manufacture, sell Remdesivir drug to fight COVID-19
- India is soon to begin the domestic production of anti-viral drug remdesivir.DCGI has granted domestic firm Glenmark Pharmaceuticals the permission to manufacture and market anti- viral drug favipiravir
- 06/21/2020
|
Solar eclipse 2020: Watch stunning visuals of surya grahan from Delhi, Mumbai, Rajasthan, Gujarat
- Solar eclipse (Surya Grahan) in India: People in India had a chance to witness the annular solar eclipse during which the Sun appears like a ring of fire today. The solar eclipse (or Surya Grahan) was be visible in different phases during the day. The first or partial phase of the solar eclipse started at 9.16 am, while the annular phase started at 10.19 am. This phase ended at 2.02 pm. The partial phase of the solar eclipse (Surya Grahan) ended at 3.04 pm. The partial phase was visible from various cities like Delhi, Mumbai, Kolkata, Chennai, Bengaluru and others. However, the annular phase was visible from some parts of north India.
- 06/21/2020
|
New quarantine rule in Delhi: No 5-day compulsory institutional quarantine now, says LG
- Earlier in the day, MoS Home Affairs G Kishan Reddy said that Delhi LG Anil Baijal who had ordered 5 days mandatory institutional quarantine for all Covid-19 patients might review his order.
- 06/20/2020
|
Defence Minister Rajnath Singh to visit Moscow next week
- Rajnath Singh was scheduled to leave on 22 June but he will now leave a day earlier, an official familiar with the minister’s programme said
- 06/20/2020
|
Yash Raj Films submits copies of contract signed by Sushant Singh Rajput to Mumbai Police
- Sushant Singh Rajput's Paani, directed by Shekhar Kapur was supposed to be his third film with YRF but they had reportedly backed out of the project.
- 06/20/2020
|
Compulsory 5-day institutional quarantine order for all Covid-19 cases in Delhi withdrawn
- Earlier today, chief minister Arvind Kejriwal met Baijal during a meeting of the Delhi Disaster Management Authority and requested the L-G to revoke the order.
- 06/20/2020
|
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate COVID-19 cases: Glenmark
- Glenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
- 06/20/2020
|
Impose restrictions on import of non-essential Chinese products: Chirag Paswan
- Lok Janshakti Party (LJP) leader Chirag Paswan on Saturday said that during the all-party meeting yesterday on the India- China border areas, his party has urged Prime Minister Narendra Modi to restrict the import of non-essential products from China in order to give a boost to the vision of self-reliant India that may affect Beijing financially.
- 06/20/2020
|
Delhi Chief Minister Arvind Kejriwal opposes move to make 5-day institutional quarantine mandatory
- Kejriwal said that ending home isolation will make people evade testing which will further increase the spread of the infection.
- 06/20/2020
|
HM hits back at Rahul Gandhi; shares video of soldier's father on allegation of 'surrendering' territory to China
- As Congress leader Rahul Gandhi made allegations on Saturday that Prime Minister Narendra Modi had "surrendered" Indian territory to China in Ladakh’s Galwan Valley, Union Home Minister Amit Shah today hit back at him and shared a video of an injured soldier's father.
- 06/20/2020
|
Galwan clash: Rahul Gandhi should give up petty politics, stand with India, says Amit Shah
- Union Home Minister Amit Shah has hit out at Congress leader Rahul Gandhi over his attacks on the Centre for the deaths of 20 Indian soldiers at the Galwan clash. Amit Shah has said Rahul Gandhi should “rise above petty politics”.
- 06/20/2020
|
Amit Shah Tweets Video Of Soldier's Father In Barb At Rahul Gandhi
- Union Home Minister Amit Shah this morning tweeted a video of a soldier's father in barb at Congress leader Rahul Gandhi, who has been attacking the government over the situation at the India-China border after clashes in Ladakh in which 20 Indian soldiers laid down their lives. In the video, an old man can be heard telling Rahul Gandhi: "Don't indulge in politics."
- 06/20/2020
|
Indo-China Row: After Ladakh Visit, PM Modi Meets President Kovind
- Catch all the updates on the India-China tensions here.
- 06/20/2020
|
5-8 million years old elephant fossil discovered in UP's Saharanpur
- In a rare discovery, an elephant fossil was found by Uttar Pradesh forest authority on Friday in Saharanpur, a district that houses a significant portion of the state's forest belt.
- 06/19/2020
|
Schizophrenic patients at higher risk for suicidal tendencies: Study
- This study shows that treatment has to include suicide prevention safety planning as well, from the very beginning.
- 06/19/2020
|
Rahul steps up attack on government over Galwan face-off, BJP leaders hit back
- Congress leader Rahul Gandhi on Friday stepped up his attack on the government over the violent face-off with China in Galwan Valley in which 20 Indian soldiers lost their lives as union minister G Kishan Reddy said he was going against the interests of nation with his remarks.
- 06/19/2020
|
Air Force Chief Visits Ladakh, Fighter Jets, Choppers Seen Over Leh
- Indian Air Force Chief Air Chief Marshal RKS Bhadauria visited Ladakh for two days - on Wednesday and Thursday - to review the preparations of the IAF, after the face-off between Indian and Chinese soldiers in the Galwan valley in which 20 Indian troops were killed on Monday night.
- 06/19/2020
|
Delhi health minister Satyendar Jain’s lung infection worsens, to be given plasma therapy
- The 55-year-old minister has now been kept on total oxygen support as his oxygen saturation level (Spo2) dipped, according to doctors treating him.
- 06/19/2020
|
India-China face-off LIVE updates: AAP, RJD not invited for PM's all-party meet
- The meeting comes in the backdrop of the massive military confrontation between India and China that occurred between 15 and 16 June in which 20 Indian soldiers were killed
- 06/19/2020
|
Class 9 Student From Kerala Designs ‘Light Motorcycle’ Using Scrap Materials
- The 'light motorcycle' comes with a petrol tank which is attached to its seats. The tank has a capacity to hold a litre of petrol in one go. Arshad mentioned that his light motorcycle can ride up to 50 kms on a full tank.
- 06/19/2020
|
China denies seizing Indian personnel during Galwan valley face-off
- Chinese Foreign Ministry spokesperson Zhao Lijian on Friday said that no India soldier was seized.
- 06/19/2020
|
"Government Was Fast Asleep": Rahul Gandhi's Fresh Attack Over Ladakh
- Unrelenting in his attacks on the centre over the Ladakh clash in which 20 Indian soldiers were killed, Rahul Gandhi tweeted today that it is "crystal clear" that the government was "fast asleep" and jawans paid the price. He posted the fresh charge hours before an all-party meeting on the India-China that his mother and Congress president Sonia Gandhi is expected to attend.
- 06/19/2020
|
Unfortunate that RJD not invited to all-party meet on Indo-China conflict: Manoj Jha
- Rashtriya Janta Dal MP Manoj Kumar Jhaon Friday expressed concerns after his party was not invited in the all-party meeting convened by Prime Minister Narendra Modi on Friday through video conferencing to discuss the ongoing border conflict with China.
- 06/19/2020
|
PM Modi to hold all-party meeting on Ladakh face-off today; Mamata to attend, AAP claims not invited
- Twenty Indian soldiers, including a colonel, were killed in a standoff with Chinese troops in eastern Ladakh’s Galwan Valley on Monday night.
- 06/19/2020
|
UP Man Marries Wooden Effigy As His 90-Year-Old-Father's Last Wish
- In Uttar Pradesh's Prayagraj a man was made to marry an effigy as his father's last wish. His 90-year-old father insisted that he wants to see all his none sons married before he dies.
- 06/19/2020
|
Coronavirus Live Updates: India reports highest single-day spike with 13,586 cases, tally crosses 3.8 lakh
- India expanded its testing strategy with the launch of a rapid antigen-based diagnostic tool after the country recorded a sharp rise in coronavirus cases. The government has also launched the first mobile laboratory for coronavirus diagnosis, which will help fight the deadly virus in rural areas. The Centre is also planning to conduct six lakh rapid antigen tests across 169 facilities to trace more cases. Meanwhile, Union Home Minister Amit Shah in a high-level meeting said Delhi and its neighbouring regions should fight the deadly virus in unison. He said Delhi-NCR should be treated as one due to the close-knit structure. At present, India has over 3.6 lakh cases and over 12,200 deaths and experts expect the figure to rise further. Fears of a second wave continue to deepen as China reported 32 new coronavirus cases, of which 25 were reported from Beijing. The US, too, has seen a significant surge in cases over the past few days. Follow IndiaToday.in for more updates on coronavirus:
- 06/19/2020
|
76 Soldiers Injured in Galwan Valley Clash with China Now in Stable Condition, Say Army Officials
- The Army had earlier clarified that all soldiers are accounted for after the violent clashes with the Chinese army.
- 06/18/2020
|
Indians Trash Chinese Products After Border Massacre
- Protests calling for boycotts on Chinese products in India gain momentum following a deadly clash between troops at the border.
- 06/18/2020
|
India-China border clash: No Indian soldier critical, to return to duty in next 15 days, say sources
- None of the soldiers left with injuries in India-China face-off at Galwan Valley are in a critical condition, news agency ANI reported quoting Indian Army sources as saying on Thursday.
- 06/18/2020
|
India to buy 21 MiG-29 and 12 Sukhoi fighter jets from Russia: Report
- The new fighter jets will be bought in a government-to-government deal with Russia with the approximate cost estimated to be ₹6,000 crore
- 06/18/2020
|
